FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
FDA General

House Panel Denounces Trump Block on Hahn Testimony

House Energy and Commerce Committee leadership denounces the White House after it blocked FDA commissioner Stephen Hahn from testifying before the Com...

Human Drugs

Medimetriks Cutting Phase 3 Enrollment After FDA Meeting

Medimetriks Pharmaceuticals says it received a Type C Meeting written response from FDA on MM36 (difamilast) for the topical treatment of mild to mode...

Human Drugs

Junshi Bio Orphan Status for Soft Tissue Sarcoma

FDA grants Junshi Biosciences an orphan drug designation for toripalimab and its use in treating soft tissue sarcoma.

Marketing

OPDP Looking at Medical Conference Drug Promotion

The CDER Office of Prescription Drug Promotion says it wants to ask medical conference healthcare professional attendees about their experiences at dr...

Medical Devices

FDA Publishes Covid-19 Molecular Test Comparisons

FDA publishes a table comparing the performance of over 50 Covid-19 molecular diagnostic tests.

Medical Devices

Acutus Medical 3D Imaging and Mapping Catheter

FDA clears a Acutus Medical 510(k) for the second-generation AcQMap 3D imaging and mapping catheter.

Biologics

Historic Data Show Vaccine Approval Risks: Lurie

Former FDA associate commissioner Peter Lurie says historic data on vaccine trials should lead to a realistic understanding that some or even all curr...

Federal Register

Down Classify Proposal on Cytomegalovirus DNA Assay Devices

Federal Register notice: FDA proposes to reclassify Class 3 cytomegalovirus deoxyribonucleic acid quantitative assay devices intended for transplant p...

Federal Register

FDA Withdraws Approval of 2 Belviq NDAs Due to Safety

Federal Register notice: FDA withdraws the approval of two Eisai NDAs for weight loss drugs Belviq tablets and Belviq XR extended-release tablets due ...

Human Drugs

ChemoCentryx NDA Accepted for Avacopan

FDA accepts for review a ChemoCentryx NDA for avacopan, an orally-administered selective complement 5a receptor inhibitor for treating antineutrophil ...